Literature DB >> 23689169

Long-acting reversible contraception: a practical solution to reduce unintended pregnancy.

G Secura1.   

Abstract

Unintended pregnancy remains a significant global public health problem; 41% of all pregnancies worldwide in 2008 were unintended. The unintended pregnancy rate is greater in less developed regions (57 per 1000 women aged 15-44 years) than in more developed regions (42 per 1000), with the United States a notable exception at a rate of 52 per 1000 women. Among US women, nearly half of unintended pregnancies are due to incorrect or inconsistent use of a contraceptive method. Long-acting reversible contraception (LARC) includes the intrauterine device and subdermal implant and offers the potential to address the problem of unintended pregnancy. LARC is extremely safe and over 99% effective at preventing pregnancy. In real-world tests LARC methods were over 20 times more effective at preventing unintended pregnancy (HRadj=21.8, 95% confidence interval, 13.7 to 34.9) compared to the contraceptive pill, patch, or ring. Despite their level of effectiveness, less than 15% of contracepting women worldwide use LARC. LARC are only infrequently contraindicated, even among younger and nulliparous women. Instead education, access, and cost are the primary barriers. In a US study of nearly 10000 women aged 14-45 years, when the three barriers were removed 75% of study participants chose a LARC method. As a result, the study reported an 80% reduction in teen births and 75% reduction in abortions among women in the cohort compared to national statistics. If we are serious about reducing unintended pregnancy, we need to be serious about increasing the use of methods that we know work. Greater LARC use and continuation has been proven to effectively reduce unintended pregnancy, including abortion and teen pregnancy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23689169

Source DB:  PubMed          Journal:  Minerva Ginecol        ISSN: 0026-4784


  10 in total

1.  Highly Effective Birth Control Use Before and After Women's Incarceration.

Authors:  Megha Ramaswamy; Hsiang-Feng Chen; Karen L Cropsey; Jennifer G Clarke; Patricia J Kelly
Journal:  J Womens Health (Larchmt)       Date:  2015-01-02       Impact factor: 2.681

2.  Assessing the effectiveness of a patient-centred computer-based clinic intervention, Health-E You/Salud iTu, to reduce health disparities in unintended pregnancies among Hispanic adolescents: study protocol for a cluster randomised control trial.

Authors:  Kathleen P Tebb; Felicia Rodriguez; Lance M Pollack; Sang Leng Trieu; Loris Hwang; Maryjane Puffer; Sally Adams; Elizabeth M Ozer; Claire D Brindis
Journal:  BMJ Open       Date:  2018-01-10       Impact factor: 2.692

3.  Assessment of utilization of long acting reversible contraceptive and associated factors among women of reproductive age in Harar City, Ethiopia.

Authors:  Kasiye Shiferaw; Abdulbasit Musa
Journal:  Pan Afr Med J       Date:  2017-11-10

4.  Contraceptive method use in the United States: trends and characteristics between 2008, 2012 and 2014.

Authors:  Megan L Kavanaugh; Jenna Jerman
Journal:  Contraception       Date:  2017-10-13       Impact factor: 3.375

5.  The Empower Nudge lottery to increase dual protection use: a proof-of-concept randomised pilot trial in South Africa.

Authors:  Omar Galárraga; Jane Harries; Brendan Maughan-Brown; Diane Cooper; Susan E Short; Mark N Lurie; Abigail Harrison
Journal:  Reprod Health Matters       Date:  2018-12

6.  Time to Long-Acting Reversible Contraceptive Uptake Over Twelve Months Postpartum: Findings of the Yam Daabo Cluster Randomized-Controlled Trial in Burkina Faso and the Democratic Republic of the Congo.

Authors:  Abou Coulibaly; Tieba Millogo; Adama Baguiya; Nguyen Toan Tran; Blandine Thieba; Armando Seuc; Asa Cuzin-Kihl; Sihem Landoulsi; James Kiarie; Rachel Yodi; Désiré Mashinda; Séni Kouanda
Journal:  Open Access J Contracept       Date:  2021-03-09

7.  Factors affecting utilization of long-acting reversible contraceptives among sexually active reproductive-age women in the pastoral community of Northeast Ethiopia: A community-based cross-sectional study.

Authors:  Kusse Urmale Mare; Ezana Abrha; Ebrahim Mohammed Yesuf; Setognal Birara Aychiluhm; Abay Woday Tadesse; Simeon Meskele Leyto; Kebede Gemeda Sabo; Getahun Fentaw Mulaw; Osman Ahmed Mohammed; Oumer Abdulkadir Ebrahim
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec

8.  Prevalence and predictors of long-acting reversible contraceptive use among sexually active women in 26 sub-Saharan African countries.

Authors:  Obasanjo Afolabi Bolarinwa; Ugochinyere Ijeoma Nwagbara; Joshua Okyere; Bright Opoku Ahinkorah; Abdul-Aziz Seidu; Edward Kwabena Ameyaw; Victor Igharo
Journal:  Int Health       Date:  2022-09-07       Impact factor: 3.131

9.  Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.

Authors:  Amy Law; Dominic Pilon; Richard Lynen; François Laliberté; Laurence Gozalo; Patrick Lefebvre; Mei Sheng Duh
Journal:  Reprod Health       Date:  2016-08-22       Impact factor: 3.223

10.  Long-acting reversible contraception use among residents in obstetrics/gynecology training programs.

Authors:  Rachel E Zigler; Jeffrey F Peipert; Qiuhong Zhao; Ragini Maddipati; Colleen McNicholas
Journal:  Open Access J Contracept       Date:  2017-01-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.